Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by Book of Award

Mr. Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Hebrew University of Jerusalem | Israel

Author Profile

Scopus

Orcid

Early Academic Pursuits

Mr. Jairus Nandwa embarked on his academic journey with a Bachelor of Technology in Industrial Microbiology and Biotechnology from The Technical University of Mombasa, Kenya. He further pursued a Master of Science in Biosciences at COMSATS University Islamabad, Pakistan, and is currently pursuing a PhD in Genetics at The Hebrew University of Jerusalem, focusing on circular RNAs, SNORDS, and miRNAs in cancer under the guidance of Professor Ruth Sperling.

Professional Endeavors

With a robust academic background, Mr. Nandwa engaged in various research experiences, including his role as a Graduate Student/Research Student at the Cancer Genetics and Epigenetics Lab, COMSATS University, Pakistan. He also served as a Laboratory Analyst during his BTech internship at the Regional Veterinary Investigation Laboratory, Kenya.

Contributions and Research Focus

Mr. Nandwa's research interests span non-coding RNAs in gene expression regulation, tumor microenvironment, biomarker/therapeutic discovery, DNA repair mechanisms, and biological data analysis. He has authored several publications and presented his research at esteemed conferences globally.

Accolades and Recognition

His notable publications include research on miRNA-4716–3p and its association with blood cancer pathogenesis, earning recognition in Non-Coding RNA Research. He has also received awards such as the Queen Elizabeth Commonwealth Scholarship and First Class Honors in BTech Industrial Microbiology and Biotechnology.

Impact and Influence

Mr. Nandwa's contributions extend beyond academia, with leadership roles in cancer education initiatives and community service engagements. His research and volunteer efforts demonstrate a commitment to advancing scientific knowledge and addressing societal challenges.

Legacy and Future Contributions

As Mr. Nandwa continues his doctoral studies and research pursuits, his dedication to understanding the intricacies of cancer biology and contributing to innovative solutions positions him as a promising researcher in the field of genetics. His leadership, academic achievements, and community impact foreshadow a legacy of scientific excellence and social responsibility.

Notable Publications

miR-4716–3p and the target AKT2 Gene/rs2304186 SNP are associated with blood cancer pathogenesis in Pakistani population 2024

In silico analysis of RPS4X (X-linked ribosomal protein) with active components from black seed (Nigella sativa) for potential treatment of multiple sclerosis 2024

Therapeutic capability of selected medicinal plants' bioactive constituents against the mutant ovarian TP53 gene; a computational approach 2023

Targeting allosteric sites on PDK-1 and PLK-1 with bioactive compounds from Daucus carota as a potential therapy for triple-negative breast cancer 2023

 

 

 

Hai Tang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by Book of Award

Dr. Hai Tang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Sun Yat-sen University | China

Author Profile

Orcid

Early Academic Pursuits

Dr. Hai Tang commenced his academic journey with a Bachelor's degree in Pharmacy and molecular biology, followed by a Master's degree in bioinformatics and molecular biology. These foundational studies laid the groundwork for his subsequent endeavors in academia and research.

Professional Endeavors

After completing his master's degree, Dr. Tang embarked on teaching and research roles at Guangdong Jiangmen Chinese Medicine College and the Southern Medical University Affiliated Maternal and Child Health Hospital of Foshan. Here, he delved into bioinformatics and molecular biology, honing his expertise and contributing to academic and scientific communities.

Contributions and Research Focus

Dr. Tang's primary research revolves around machine learning, bioinformatics, and molecular biology, particularly in the realms of preeclampsia, Alzheimer's disease, and cancers. He focuses on identifying novel biomarkers to enhance early diagnosis and treatment strategies for these diseases. His contributions include participation in various research projects funded by prestigious institutions and the publication of several SCI papers.

Accolades and Recognition

Dr. Tang's notable achievements include publications in esteemed journals like Computers in Biology and Medicine. He has been involved in impactful research initiatives, demonstrating his ability to translate conceptual ideas into tangible outcomes.

Impact and Influence

Through his dedication to advancing machine learning, bioinformatics, and molecular biology, Dr. Tang has made significant contributions to his field. His research outcomes have the potential to influence clinical practice and contribute to advancements in medical diagnostics and treatments.

Legacy and Future Contributions

Dr. Tang's commitment to staying abreast of the latest advancements and his active engagement in academic and industry communities position him as a driving force in future research endeavors. His legacy lies in his contributions to cutting-edge research and the practical application of his findings in real-world medical and biological contexts

Notable Publications

Lysosome-related biomarkers in preeclampsia and cancer: Machine learning and bioinformatics analysis 2024

Role of breastfeeding on maternal and childhood cancers: An umbrella review of meta-analyses 2023 (2)

Lycopene protects neuroblastoma cells against oxidative damage via depression of ER stress 2020 (9)

Lycopene alleviates oxidative stress via the PI3K/Akt/Nrf2pathway in a cell model of Alzheimer’s disease 2020 (23)

Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mce 2019 (19)

 

 

Assist Prof  Dr. Andreas Agathangelidis | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by Book of Award

Assist Prof  Dr. Andreas Agathangelidis | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

National and Kapodistrian University of Athens | Greece

Author Profile

Google Scholar

Early Academic Pursuits

Andreas Agathangelidis initiated his scientific journey at Thessaloniki's "G. Papanikolaou" hospital, delving into Chronic Lymphocytic Leukemia (CLL) and antigens for his diploma thesis. Subsequently, his Ph.D. at Aristotle University focused on immunogenetics in B-cell malignancies.

Professional Endeavors

Agathangelidis conducted groundbreaking studies during his Ph.D., notably refining CLL molecular classification using a sizable patient cohort. His postdoctoral research at San Raffaele Scientific Institute, Milan, explored CLL and Monoclonal B lymphocytosis (MBL) under Professor Paolo Ghia, broadening his expertise in advanced genetic methodologies.

Contributions and Research Focus

Significant contributions include expansive studies on CLL patients and the largest worldwide series on Mantle Lymphoma (MCL), emphasizing the role of antigens in disease progression. He conducted diverse immunoprofiling studies, exploring gene rearrangements and subtyping based on immunogenetics, oncogenetics, and immunophenotype integration.

Accolades and Recognition

Agathangelidis' pioneering research secured recognition, including fellowships from the HFRI Foundation and industry funding from Gilead Sciences. His leadership in the "CLLon" project, studying the B cell receptor's role in CLL and MBL development, represents a significant achievement in cancer genetics.

Impact and Influence

His work has significantly challenged prevailing views in disease mechanisms, refining classifications, and paving the way for targeted therapies for B-cell malignancies. The extensive studies he led have had a substantial impact on understanding disease ontogeny and the development of potential treatments.

Legacy and Future Contributions

Currently an Assistant Professor at the National and Kapodistrian University of Athens, Agathangelidis continues his research using advanced NGS technologies. His focus on elucidating the B cell receptor's role in CLL and MBL development through deep sequencing and bioinformatics is poised to bring forth notable advancements in cancer genetics and potential therapeutic avenues.

Notable Publications

Recurrent mutations refine prognosis in chronic lymphocytic leukemia 2014 (219)

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study 2015 (179)

Antigen receptor stereotypy in chronic lymphocytic leukemia 2016 (99)